These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 1755460)

  • 1. Use of the Home Ovarian Monitor in pregnancy avoidance.
    Brown JB; Holmes J; Barker G
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of ovarian activity by measurement of urinary excretion rates using the Ovarian Monitor, Part IV: the relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the post-ovulatory infertile period.
    Blackwell LF; Vigil P; Alliende ME; Brown S; Festin M; Cooke DG
    Hum Reprod; 2016 Feb; 31(2):445-53. PubMed ID: 26677961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The validation of the Billings ovulation method by laboratory research and field trials.
    Billings JJ
    Acta Eur Fertil; 1991; 22(1):9-15. PubMed ID: 1746210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using an ovarian monitor as an adjunct to natural family planning.
    Cavero C
    J Nurse Midwifery; 1995; 40(3):269-76. PubMed ID: 7798132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural regulation of fertility.
    Howie PW
    Br Med Bull; 1993 Jan; 49(1):182-99. PubMed ID: 8324608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prototype for ovulation detection: pros and cons.
    Lasley BL; Shideler SE; Munro CJ
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2003-7. PubMed ID: 1755459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
    Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
    Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personal hormone monitoring for contraception.
    Bonnar J; Flynn A; Freundl G; Kirkman R; Royston R; Snowden R
    Br J Fam Plann; 1999 Jan; 24(4):128-34. PubMed ID: 10023097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: reliability of home testing.
    Blackwell LF; Vigil P; Gross B; d'Arcangues C; Cooke DG; Brown JB
    Hum Reprod; 2012 Feb; 27(2):550-7. PubMed ID: 22131389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More about natural family planning.
    Gallagher J
    Aust Fam Physician; 1983 Nov; 12(11):786-92. PubMed ID: 6667188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective multicentre trial of the ovulation method of natural family planning. II. The effectiveness phase.
    Fertil Steril; 1981 Nov; 36(5):591-8. PubMed ID: 7308503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal monitoring of ovarian activity using the Ovarian Monitor, part I. Validation of home and laboratory results obtained during ovulatory cycles by comparison with radioimmunoassay.
    Blackwell LF; Brown JB; Vigil P; Gross B; Sufi S; d'Arcangues C
    Steroids; 2003 May; 68(5):465-76. PubMed ID: 12798498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prediction and/or detection of ovulation by means of urinary steroid assays.
    Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
    Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective multicentre trial of the ovulation method of natural family planning. I. The teaching phase.
    Fertil Steril; 1981 Aug; 36(2):152-8. PubMed ID: 7021189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL; Sweeting VM; Hillier H; Baird DT
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian function after the menarche and hormonal contraception.
    Borsos A; Lampé L; Balogh A; Csoknyay J; Ditròi F; Székely P
    Int J Gynaecol Obstet; 1988 Oct; 27(2):249-53. PubMed ID: 2903093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of the Bioself 110 electronic fertility indicator as a contraceptive aid.
    Flynn A; Pulcrano J; Royston P; Spieler J
    Contraception; 1991 Aug; 44(2):125-39. PubMed ID: 1893707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further analysis of contraceptive failure of the ovulation method.
    Trussell J; Grummer-Strawn L
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2054-9. PubMed ID: 1755470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptothermal and hormonal markers of potential fertility in climacteric women.
    Flynn AM; James P; Collins WP; Royston P
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):1987-9. PubMed ID: 1755454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Day-Specific Serum LH, Estradiol, and Progesterone with Mira
    Usala SJ; Vineyard DD; Kastis M; Trindade AA; Gill HS
    Medicina (Kaunas); 2024 Jul; 60(8):. PubMed ID: 39202489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.